Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: Photonstar Led Group PLC

Market Cap 5.71K 4.99K 4.61K 4.31K 8.08K 539K 8.14K 54.81K 21.33K 265K 21.43K 20.96K 921K P/E 2019
-0.01x
P/E 2020 -0.02x
Enterprise Value -78.29K -68.41K -63.28K -59.06K -111K -7.4M -112K -752K -293K -3.64M -294K -288K -12.64M EV / Sales 2019
-
EV / Sales 2020 -
Free-Float
76.48%
Yield 2019 *
-
Yield 2020 -
Manager TitleAgeSince
Director of Finance/CFO 65 14/05/2021
Chief Tech/Sci/R&D Officer 61 02/01/2025
Director TitleAgeSince
Director/Board Member 45 29/01/2019
Chairman 70 21/05/2019
Director/Board Member 61 14/05/2021
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-99.07% - - 3.54M
+1.28%+6.33%+17.79%+103.91% 9.57B
-5.51%+0.99%+711.88% - 5.12B
+0.67%+1.36%-4.91%-16.55% 2.83B
-2.20%-5.62%+2.95%-9.60% 1.99B
+0.20%+4.55%-16.25%-9.98% 999M
-2.11%+3.33%+61.04%+98.78% 947M
-4.17%-4.40%+73.78%+17.42% 856M
-5.32%+7.30%+117.78% - 799M
-2.17%-8.55%+94.44%+131.29% 776M
Average -1.93%+0.67%+117.61%+45.04% 2.65B
Weighted average by Cap. -1.25%+2.63%+170.74%+62.81%

Financials

2019 2020
Net sales - -
Net income -832K -727K -672K -628K -1.18M -78.63M -1.19M -7.99M -3.11M -38.66M -3.12M -3.06M -134M -306K -267K -247K -231K -433K -28.92M -437K -2.94M -1.14M -14.22M -1.15M -1.12M -49.39M
Net Debt -378K -330K -306K -285K -535K -35.72M -539K -3.63M -1.41M -17.56M -1.42M -1.39M -61.01M -84K -73.4K -67.89K -63.37K -119K -7.94M -120K -807K -314K -3.9M -315K -309K -13.56M
Logo Photonstar Led Group PLC
Cizzle Biotechnology Holdings PLC is a United Kingdom-based diagnostics developer of early cancer tests. The Company is focused on early detection of lung cancer via the development of an immunoassay test for the CIZ1B biomarker. CIZ1B is a variant of CIZ1, a naturally occurring cell nuclear protein involved in protecting deoxyribonucleic acid (DNA). Its CIZ1B biomarker detects lung cancer at its earliest and most treatable stage. It is designed as a simple blood test, which enables early diagnosis before symptoms appear-when treatment options can transform outcomes for patients and families.
Employees
-
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!